Patent details

EP1379625 Title: CD4+CD25+ REGULATORY T CELLS FROM HUMAN BLOOD

Basic Information

Publication number:
EP1379625
PCT Application Number:
PCT/EP/2002/002671
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027273978
PCT Publication Number:
WO/2002/072799
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CD4+CD25+ REGULATORY T CELLS FROM HUMAN BLOOD
French Title of Invention:
LYMPHOCYTES T CD4+CD25+ REGULATEURS ISSUS DE SANG HUMAIN
German Title of Invention:
CD4+CD25+ REGULATORISCHE T-ZELLEN AUS MENSCHLICHEM BLUT
SPC Number:

Dates

Filing date:
12/03/2002
Grant date:
30/06/2010
EP Publication Date:
30/06/2010
PCT Publication Date:
19/09/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/01/2004
EP B1 Publication Date:
30/06/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/03/2011
Expiration date:
12/03/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/03/2002
 
 

Name:
Argos Therapeutics Inc.
Address:
4233 Technology Drive, Durham, NC 27704, United States (US)

Inventor

1

Name:
DIECKMANN Detlef
Address:
Germany (DE)

2

Name:
SCHULER Gerold
Address:
Germany (DE)

Priority

Priority Number:
01106033
Priority Date:
12/03/2001
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C12N 5/07;

Publication

European Patent Bulletin

Issue number:
202008
Publication date:
19/02/2020
Description:
Opposition rejected; Patent maintained as granted
Filing date Document type Number of pages